Abstract
Cellular senescence and the senescence-associated secretory phenotype (SASP) have been implicated in osteoarthritis (OA). This study aims to determine whether multi-kinase inhibitor YKL-05-099 (Y099) has potential in senescence elimination and OA therapy and whether delivering Y099 by nanoliposmal hydrogel improves the performance of the kinase inhibitor. Y099 inhibited IL-1β-induced inflammation and catabolism and promoted anabolism of chondrocytes. To attenuate the inhibition of cell viability, nanoliposomal Y099-loaded thermosensitive hydrogel (Y099-Lip-Gel) was developed for sustained release and toxicity exemption. Notably, Y099-Lip-Gel exhibited a pronounced effect on promoting anabolism and suppressing catabolism and inflammation without causing the inhibition of chondrocyte viability. Moreover, Y099-Lip-Gel remarkably increased the master regulator of chondrocyte phenotype Sox9 expression. After four intra-articular injections of Y099-Lip-Gel in the OA murine model, the histological lesions of cartilage were attenuated by Y099-Lip-Gel with subchondral bone loss and osteoclast formation inhibited. Transcriptomic analysis and experimental validations revealed that Y099-Lip-Gel suppressed cellular senescence by inhibiting the expression of senescence inducers and SASP factors. Furthermore, the phosphoproteomic analysis showed that Y099-Lip-Gel exerted a significant influence on kinome phosphorylation, inhibiting the MAPK and NF-κB signaling activations. The protective effects of Y099-Lip-Gel were also validated in cultured human OA cartilage explants. In conclusion, nanoliposomal Y099-loaded thermosensitive hydrogel has considerable potential in OA therapy. Nanoliposome-based hydrogel system has strength in reducing kinase inhibition-induced cytotoxicity, enhancing cellular tolerance to kinome perturbation, and improving the performance of protein kinase inhibitors. Senescence elimination via toxicity-exempted kinome perturbations achieved by advanced nanotechnology is a promising strategy for OA.
Graphical Abstract
Similar content being viewed by others
Avoid common mistakes on your manuscript.
1 Introduction
Osteoarthritis (OA) is a common age-related degenerative joint disease, characterized by progressive articular cartilage degradation, synovial inflammation, osteophyte formation, subchondral bone lesions, and abnormal angiogenesis, which causes chronic pain, swelling, stiffness, and motion restriction [1, 2]. Due to the high incidence, the absence of effective therapy for early OA, and the high cost of joint replacement for advanced OA, OA has become a worldwide challenge. Recent research advances in the mechanisms of OA have promoted the understanding of this disease and indicated some novel therapies based on these findings, which may be promising for OA therapy. Cellular senescence has been implied in a wide range of age-related diseases, including OA [3, 4]. As a hallmark of aging, accumulated cellular senescence is a permanent state of cell-cycle arrest accompanied by the release of a group of pro-inflammatory cytokines, chemokines, matrix metalloproteases (MMPs), and growth factors with autocrine, paracrine, and endocrine activities, which is a senescence-related secretome termed senescence-associated secretory phenotype (SASP) [5]. Cellular senescence is caused by oxidative stress, DNA damage, and dysfunctional oncogenes, contributing to inflammation, the decline of the tissue regenerative potential and function, and tumorigenesis [6]. Due to the intrinsic relationship between cellular senescence and aging and aging-related inflammation, targeting senescence is a promising novel strategy for OA therapy.
Kinome is a collection that comprises 538 kinases playing critical functions by catalyzing protein phosphorylation and regulating intracellular signaling events [7]. Due to the critical roles of protein kinases in the mechanisms of diseases, such as inflammation [8] and aging [9], small molecule kinase inhibitors have been introduced into research and approved for clinical applications [10]. Multiple kinases and related signaling pathways, such as the mitogen-activated protein kinase (MAPK) pathway and NF-κB pathway, have also been implied in reactive oxygen species (ROS) or mechanical stress-induced cellular senescence and the SASP productions in OA [38]. Gene expression levels were indicated by FPKM (fragment per kilobase of transcript per million mapped reads). Principal component analysis (PCA) was used to determine the overall difference in transcriptome between each group. Differentially expressed genes (DEGs) were identified by the criteria of FDR < 0.05 using the R package DESeq2 (v1.38.2) [39]. The perturbation amplitude of gene expression induced by the treatments was defined by expression variance calculated by the absolute value of the difference in normalized gene expression (FPKM) between the two groups to identify the robustly regulated genes. To identify the commonly prioritized genes in the ranked list of up- or down-regulated genes induced by IL-1β and in the ranked list of the down- and up-regulated genes by Y099-Lip-Gel, which were ranked in descending order of expression variance values, normalized rescue score was defined using the R package RobustRankAggreg (v1.1) [40]. By comparing the perturbation amplitude induced by IL-1β or Y099-Lip-Gel, Type-1 and Type-2 rescued genes were defined. Type-1 genes were defined as the completely rescued ones, whose perturbation amplitudes induced by Y099-Lip-Gel were greater than the ones induced by IL-1β. Type-2 genes were the partially rescued ones whose perturbation amplitudes induced by Y099-Lip-Gel were smaller than the ones induced by IL-1β. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses and gene set enrichment analysis (GSEA) were performed using the R package clusterProfiler (v3.11) [41]. Senescence-related gene sets were sourced from CellAge (Build 2) [42]. For GSEA, FDR < 0.25 was considered significant.
2.11 Phosphoproteomic analysis
Chondrocytes were prepared and treated as they were done in the RNA-seq study. Two biological replicates of each group were prepared for phosphoproteomic analysis. After the drug treatment, chondrocyte pallets were collected. Subsequent protein sample preparation and liquid chromatography-tandem mass spectrometry (LC–MS/MS) were performed at **gjie PTM Biolab Co., Ltd. (China). Briefly, the protein of chondrocyte pallets was extracted, and the protein samples underwent trypsin digestion to generate peptide mixtures which were further labeled with tandem mass tag (TMT) (ThermoFisher Scientific, USA) according to the manufacturer’s instructions. The TMT-labeled peptides were fractionated by high pH reverse-phase HPLC using Agilent 300 Extend C18 column (5 μm particles, 4.6 mm ID, 250 mm length). Then, the phosphopeptides of each fraction were enriched with immobilized metal affinity chromatography (IMAC)-TiQ2 and analyzed using LC–MS/MS. Data were processed using the MaxQuant search engine (v.1.5.2.8) and analyzed using bioinformatics methods [43, 44]. Phosphosites with a ratio of estimated phosphorylation levels > 1.3 or < 1/1.3 and a coefficient of variation (CV) < 0.1 were considered significant [45]. Kinome tree was visualized using Coral [46]. KEGG enrichment analysis and GSEA of the significant phosphosites were performed using the R package clusterProfiler (v3.11) [41]. For GSEA, FDR < 0.25 was considered significant.
2.12 Animal study
All the protocols of animal study were approved by the Experimental Animal Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China) (IACUC: 2737). Sixty 8-week-old male C57BL/6 J mice were purchased from Wuhan Beiente Biology Science and Technology Co., Ltd. and fed in a specific-pathogen-free animal environment. The OA model was established by the surgical destabilization of the medial meniscus (DMM) after inhalation-induced anesthesia with isoflurane. The sham animals were subjected to the surgical incision of the joint cavity and excision of the anterior fat pad. The mice were randomly and evenly assigned into five groups, including (1) sham; (2) DMM; (3) DMM treated with the hydrogel loaded with drug-free nanoliposomes (Lip-Gel) (DMM-0 mg/mL); (4) DMM treated with Y099-Lip-Gel loaded with 1.5 mg/mL Y099 (DMM-1.5 mg/mL); and (5) DMM treated with Y099-Lip-Gel loaded with 3.0 mg/mL Y099 (DMM-3.0 mg/mL). One-week post-surgery, the mice were treated with the first intra-articular injections of 10 μL drugs and subsequently treated every 2 weeks for 6 weeks. The mice of the sham or DMM group received 10 μL saline solution. The mice were sacrificed, and the right knee joints were collected for analysis after all the injections were finished. The major organs, including the heart, liver, spleen, kidney, and testis, were fixed by 4% PFA and subjected to hematoxylin and eosin (H&E) staining following standard protocol.
2.13 Microcomputed tomography analysis
After the fixation in 4% paraformaldehyde, microcomputed tomography (μCT) analysis of the joint was conducted using Scanco vivaCT 40 (Scanco Medical, Switzerland) with the following parameters of calcified tissue visualization: voxel size of 10 µm resolution, voltage of 100 kV, current of 98 µA, and integration time of 300 ms. The 3D reconstructed images and quantitative analysis data were generated by 3D built-in software. The parameters of the tibial subchondral bone, including trabecular bone volume (BV)/tissue volume (TV) fraction (BV/TV), trabecular thickness (Tb. Th), trabecular spacing (Tb. Sp), and trabecular number (Tb. N), were measured as previously described [47]. The surface roughness analysis was performed in the medial femoral condyle using ImageJ software v1.53 k (National Institutes of Health, USA).
2.14 Histomorphometric and immunohistochemistry analyses
The knee joints were decalcified in 10% ethylenediaminetetraacetic acid (EDTA) for 30 days after the fixation in 4% paraformaldehyde at 4 °C, subsequentially embedded in paraffin, and sliced into 5-μm sections. Safranin O (Saf-O)/fast green staining was performed for histological assessment of cartilage to observe chondrocyte morphology and arrangement, articular cartilage structure, and extracellular matrix abundance. The OA Research Society International (OARSI) scoring system (0 to 6) and modified Mankin scoring system (0 to 16) were used to semi-quantitatively analyze cartilage lesions [48, 49]. Saf-O abundance reflecting proteoglycan content was scored (0 to 12) according to the previous studies [47, 50]. The mean value of three individual scores assessed by three blinded researchers was calculated for one slide, and the mean score of randomly chosen ten slides was calculated to represent one sample. A higher score indicates more advanced histological lesions of OA. Tartrate-resistant acid phosphatase (TRAP) staining was performed to analyze the osteoclast number in the femoral condyle as previously described [51]. Immunohistochemistry (IHC) analyses of the joints and human cartilage explants were performed as previously described [52].
2.15 Human cartilage harvest, culture, and treatment
Human tissue harvest was approved by the Human Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China) (approval number: TJ-IRB20220946). Six OA patients (mean age, 67 years; range, 59–72 years; male: 4, female: 2) who underwent total knee arthroplasty (TKA) at the Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, in 2022 were enrolled in this study. None of them had other systemic diseases. Written informed consent was acquired from each patient before the sample was obtained. The medial femoral condyles were isolated from the OA patients during surgery and quickly transformed to the laboratory on ice for further processing. The medial femoral condyles were washed three times using PBS and further immersed in PBS, followed by the removal of the soft tissue clearance on the cartilage surface. The cartilage explants sized in 5 × 5 × 5 mm3 were excised using a surgical saw and immersed in PBS for later treatment. The cartilage explants were cultured in an incubator containing 5% CO2 at 37 °C with DMEM/F12 medium supplemented with 10% FBS, 1% penicillin/streptomycin, and human IL-1β (10 ng/mL). For drug treatment, the cartilage explants from the same patient were treated drug-free Lip-Gel or Y099-Lip-Gel (Y099: 5 μM) for 48 h. Briefly, the transwell inserts added with solidified Y099-Lip-Gel (Y099: 5 μM) were plated into the cell culture wells with the insert bottoms immersed in the culture medium. After 48-h treatment, the cartilage explants were fixed in 4% paraformaldehyde at 4 °C for 24 h and decalcified in 10% EDTA for 30 days, followed by the standard procedures of IHC analysis.
2.16 Statistical analysis
All data analyses were conducted using GraphPad Prism software v7.0 (GraphPad, USA). Comparisons between the two groups were performed by unpaired t-test. Comparisons among multiple groups were performed by one-way analysis of variance (ANOVA) followed by Tukey’s test. A p value < 0.05 was recognized as significant. All the experiments were repeated three times, and independently triplicate data were displayed as means and standard deviations.
3 Results
3.1 Y099 notably suppresses inflammation and catabolism and promotes anabolism in IL-1β-treated chondrocytes while causing viability inhibition
The cytotoxicity of Y099 was first checked by the CCK8 method (Fig. 1A and B). After 24-h treatment, the cell viability of chondrocytes was notably suppressed by Y099 (0.5–5 μM) in a dose-dependent manner (~ 20% decreased at 1.0 μM; ~ 50% at 5.0 μM) (Fig. 1B). To assess whether Y099 affects the anabolism and catabolism of IL-1β-treated chondrocytes, the expression of cartilage anabolic indicators aggrecan and Type-II collagen and catabolic indicator MMP-13 was detected by IF analyses (Fig. 1C). IL-1β (5 ng/mL) suppressed the abundance of aggrecan and Type-II collagen and induced the expression of MMP-13, whereas Y099 (5.0 μM) rescued the effects of IL-1β by increasing aggrecan and Type-II collagen and inhibiting MMP-13 after 24-h treatment. These findings were validated by western blot (Fig. 1D and E). The western blot showed that MMP-3, a catabolic indicator like MMP-13, was more sensitive to the Y099 treatment, which was ~ 50% decreased by Y099 (0.5 μM) and almost completely inhibited by Y099 (5.0 μM). In line with the changes of aggrecan and Type-II collagen, SOX9, the master regulator of chondrocyte phenotypes, was also moderately increased by the Y099 treatment. Furthermore, the expression of inflammation indicators COX and iNOS were notably enhanced by IL-1β, whereas Y099 showed a pronounced inhibition in COX and iNOS even at a low concentration (0.5 μM) (Fig. 1D and E). These findings demonstrated that Y099 has a remarkable suppressive effect on inflammation and catabolism and a moderate promotion of anabolism while causing considerable viability inhibition.
3.2 Y099-Lip-Gel remains beneficial effects of Y099 on chondrocytes, enhancing the promotion of Sox9 expression without causing viability inhibition
To overcome the limitation of Y099 in cytotoxicity, Y099-Lip-Gel was developed for sustained release and toxicity exemption. As shown in Fig. 2A, Y099 is loaded in the lipid bilayer of nanoliposomes. The Y099-loaded nanoliposomes with a mean particle size of 145.6 nm were evenly dispersed (Fig. 2B). The PLGA1500-PEG1200-PLGA1500 polymers (25 wt%) displayed temperature-dependent solution-gel transition behavior, which exhibited solution-like behavior at 4 °C and room temperature (25 °C) and formed a gel at body temperature (37 °C) (Fig. 2C and D). The modulus-temperature cure showed that the maximum temperature of the modulus of the polymer solution (25 wt%) was 33.8 °C (Fig. 2E). The modulus-time cure demonstrated that the gelation time was 99.2 s at 37 °C (Fig. 2E), which is appreciated for performing the intra-articular injections of this gel-forming polymer solution and for the retention in the joint by gelation. SEM showed that the Y099-loaded nanoliposomes were evenly dispersed in the hydrogel (Fig. 2F). Thermogravimetric analysis showed that the hydrogel promoted the thermal stability of Y099-loaded nanoliposomes (Fig. 2G). Moreover, the drug release assay showed that more than 80% of Y099 was released from the nanoliposome in 5 days, whereas the hydrogel prolonged the drug release and more than 30% drug could be retained on the 20th day (Fig. 2F).
To determine whether the sustained release of Y099 could reduce cytotoxicity, the viability of the chondrocytes treated with Y099-Lip-Gel loaded with 1.0, 2.5, 5.0, 10.0, or 100.0 μM Y099 for 72 h was assessed by the CCK8 method. As shown in Fig. 3A, nanoliposomes or hydrogel themselves show no cytotoxicity, and Y099-Lip-Gel shows good cytocompatibility at the concentration from 1.0 to 5.0 μM. Of note, Y099-Lip-Gel (5.0 μM) showed considerable strength in toxicity exemption when compared with Y099 at 5.0 μM (Fig. 3B). To investigate whether Y099-Lip-Gel remained the beneficial effects of Y099 on chondrocytes, Alcian blue staining of micromass was performed to check the matrix abundance under the treatment of Y099-Lip-Gel. As shown in Fig. 3C, IL-1β reduces the matrix abundance of micromass, whereas Y099-Lip-Gel rescues this reduction caused by IL-1β. Western blot analyses showed that Y099-Lip-Gel remained the suppressive effects on the IL-1β-induced catabolic and inflammatory indicators (Fig. 3D). Although the suppressions of COX and iNOS were attenuated due to sustained release, the effects on promoting SOX9 and inhibiting MMP-13 were enhanced (Fig. 3D). These findings of MMP-3, MMP-13, and SOX9 were further validated by qPCR, which showed that Y099 regulated the expression of these indicators at the transcriptional levels (Fig. 3E). Of note, both western blot and qPCR showed that Y099-Lip-Gel exhibited an enhanced promotive effect on Sox9 expression which is critical for cartilage homeostasis and OA development, suggesting a notable potential of Y099-Lip-Gel in OA therapy. These findings together indicated that sustained release of Y099 achieved by thermosensitive hydrogel loaded with nanoliposomes succeeded in toxicity exemption and reached a good balance on anabolism promotion and catabolism inhibition.
3.3 Y099-Lip-Gel attenuates histological cartilage lesions and subchondral bone loss in the OA murine model
To check whether hydrogel prolongs the retention of nanoliposomes in the joint, 10 μL PBS, Cy5-labeled nanoliposomes, hydrogel, or hydrogel loaded with Cy5-labeled nanoliposomes were administrated by intra-articular injections (Fig. 4A). The Cy5 fluorescence was dismissed 48 h after the injection of Cy5-labeled liposomes, whereas the hydrogel preserved the fluorescence for 72 h (Fig. 4B and C). To evaluate the potential of Y099-Lip-Gel in OA therapy, the murine OA model was established by DMM surgery and received four injections of Y099-Lip-Gel by intra-articular administration for 2 months (Fig. 4D). H&E staining showed that Y099-Lip-Gel did not induce appreciable histological changes in the key organ after the 2-month treatment (Supplemental Fig. 1). The Saf-O/fast green staining of articular cartilage showed that DMM surgery induced typical OA-like cartilage degeneration, characterized by matrix loss, disorganized chondrocyte sequence, and fissures, whereas these changes were attenuated by Y099-Lip-Gel (Fig. 4E). The histological lesions of cartilage were further quantitatively analyzed by OARSI and modified Mankin scoring system. As shown in Fig. 4G, the DMM and DMM-0 mg/mL groups both show a considerable increase in OARSI and Mankin scores. However, both treatment groups showed lower scores than the DMM or DMM-0 mg/mL groups (Fig. 4G). Moreover, Saf-O scoring was used as a supplementary assessment of matrix loss, which showed that Y099-Lip-Gel partially rescued the elevation of the Saf-O score induced by DMM (Fig. 4G). To further assess the anabolic effect of Y099-Lip-Gel, IHC analyses of aggrecan were performed. The results showed that Y099-Lip-Gel attenuated the loss of aggrecan induced by DMM (Fig. 4F), which is consistent with the quantitative analyses of aggrecan positive area (Fig. 4G). These findings suggested that Y099-Lip-Gel attenuated histological cartilage lesions and promoted aggrecan synthesis against trauma-induced OA.
Osteophyte or bone spur formation is characterized in OA patients and experimental models, causing OA-related chronic pain. The 3D images of the joints developed by μCT analysis demonstrated that the obvious osteophytes were formed on the femoral surface of the DMM group, whereas osteophyte formation was ameliorated by Y099-Lip-Gel (Fig. 5A). The surface roughness analyses of the medial femoral condyle showed that the roughness was notably increased in the DMM group, whereas Y099-Lip-Gel attenuated the increased roughness of bone surface induced by DMM (Fig. 5B). Since subchondral bone is a critical element of the osteochondral unit in maintaining cartilage homeostasis, the bone mass and microstructure of tibial subchondral bone were analyzed by μCT (Fig. 5C). The coronal section of femurs and tibias showed that subchondral bone was reduced in the DMM group compared with the sham group, whereas Y099-Lip-Gel efficiently prevented the subchondral bone loss induced by DMM (Fig. 5D). The quantitative analyses of tibias showed that Y099-Lip-Gel exhibited an efficient action in increasing Tb. Th, thus leading to an increased BT/TV (Fig. 5D). Since osteoclast is an essential regulator of subchondral bone remodeling, subchondral osteoclast numbers were analyzed by TRAP staining. As shown in Fig. 5E and Supplemental Fig. 2, the osteoclast number is increased in the DMM group whereas decreased in the Y099-Lip-Gel groups. These findings indicated that Y099-Lip-Gel inhibited the OA-related osteophyte formation, subchondral bone loss, and osteoclast formation in the OA murine model.
3.4 Y099-Lip-Gel recuses IL-1β-induced gene expression and regulates OA-related signaling pathways
To decipher the mechanism by which Y099-Lip-Gel is against OA, transcriptomic analyses by RNA-seq were performed (Fig. 6A). The PCA result indicated the overall transcriptomic similarity and differences of samples (Fig. 6B). As shown in Fig. 6B, IL-1β induced a transcriptomic shift in the PC1 axis, which was opposed to the effect of Y099-Lip-Gel on the transcriptomic shift in the PC1 axis. Compared with the Ctl-Veh group, 2319 DEGs were identified in the Ctl-IL-1β group, including 1258 up-regulated and 1061 down-regulated genes (Fig. 6C). However, compared with the Ctl-IL-1β group, 2922 up-regulated and 2917 down-regulated genes were identified in the Y099-IL-1β group (Fig. 6C). Of note, Mmp3, Chil1, Saa3, Fth1, Lcn2, Spp1, Mt2, Cxcl1, and Ldha were notably up-regulated by IL-1β, whereas they were remarkably down-regulated by Y099-Lip-Gel (Fig. 6C). Indeed, ~ 69.4% of up-regulated genes (n = 805) and ~ 46.6% of down-regulated genes (n = 494) induced by IL-1β were rescued by Y099-Lip-Gel (Fig. 6D). Moreover, two types of rescued genes were further characterized by comparing the perturbation amplitudes of gene expression (Fig. 6E). The Type-1 genes (n = 889; 68.4%) were defined as completely rescued genes since the perturbation amplitudes induced by Y099-Lip-Gel were greater than the ones induced by IL-1β. The Type-2 genes (n = 410; 31.6%) were defined as partially rescued genes, which were much less than the Type-1 genes (Fig. 6E). To identify the most significantly rescued genes, a robust rank aggregation algorithm was employed to define a normalized rescued score which was to identify the common polarized gene in the comparisons between the Ctl-IL-1β and Ctl-Veh groups or between the Y099-IL-1β and Ctl-IL-1β groups and reflected the rescuing efficacy of Y099-Lip-Gel to IL-1β treatment at gene levels. According to the normalized rescued scores, the top 30 rescued genes are shown in Fig. 6F. In addition to catabolic genes such as Mmp3 and Mmp13, inflammation-related genes (e.g., Nos2, Cx3cl1, Ccl2, Cxcl3, and Cxcl10) and tissue remodeling-related genes (e.g., Spp1, Timp1, and Ogn) were also identified in the top rescued gene list. Of note, Cdkn1a, which encodes cyclin-dependent kinase inhibitor 1A (P21Cip1) and is a critical regulator and indicator of cellular senescence, was remarkably induced by IL-1β but suppressed by Y099-Lip-Gel. To understand the pathways related to these recused genes, these genes were subjected to GO and KEGG enrichment analyses (Fig. 6G). The pathways related to tissue remodeling and homeostasis pathways (e.g., tissue migration, ECM organization), inflammation pathways (e.g., inflammation response, cytokine production), stress pathway (e.g., response to oxidative stress), cartilage homeostasis (e.g., cartilage development, chondrocyte differentiation), bone homeostasis (e.g., ossification, osteoblast differentiation), and protein kinase activity (e.g., regulation of protein serine/threonine kinase activity, negative regulation of phosphorylation) were identified by GO analyses (Fig. 6G). Moreover, KEGG analyses showed that the rescued genes were related to OA-related signaling pathways, such as TNF, IL-17, NF-κB, and MAPK signaling pathways. Of note, KEGG analyses also indicated that cellular senescence was significantly associated with the effect of Y099-Lip-Gel on transcriptome (Fig. 6G).
3.5 Y099-Lip-Gel suppresses cellular senescence by inhibiting senescence inducers and the senescence-associated secretory phenotype factors
Due to the findings of transcriptome strongly suggesting the connection between Y099-Lip-Gel and cellular senescence, the senescence-related gene sets were further investigated by bioinformatics. GSEA showed that IL-1β had the potential in promoting senescence-related genes, whereas Y099-Lip-Gel had a suppressive effect on them (Fig. 7A). Moreover, IL-1β significantly activated senescence inducers and inhibited the senescence suppressors (Fig. 7A). Although Y099-Lip-Gel showed moderate effects on senescence suppressors, it notably inhibited the expression of senescence inducers (FDR < 0.05) (Fig. 7A). Leading edge analyses showed the senescence-related genes significantly up-regulated by IL-1β but down-regulated by Y099-Lip-Gel (Fig. 7A). Of note, senescence inducer Serpine1 was the top 2 in the leading edge of IL-1β and the top 1 in the leading edge of Y099-Lip-Gel, indicating its critical role in the mechanism of Y099-Lip-Gel against OA (Fig. 7A). To validate whether Y099-Lip-Gel suppresses senescence, β-galactosidase staining was performed, which showed that Y099-Lip-Gel reduced IL-1β-induced senescence of chondrocytes (Fig. 7B). The IF of γH2AX showed that Y099-Lip-Gel decreased IL-1β-induced elevation of γH2AX abundance in nuclei, suggesting that IL-1β-induced DNA damage was rescued by Y099-Lip-Gel (Fig. 7C). The suppression of Y099-Lip-Gel on senescence indicators P21Cip1 and P16INK4A was further validated by western blot (Fig. 7D). Moreover, the expression of Cdkn1a and the rescued SASP factors (n = 15) were characterized (Fig. 7E) and validated by qPCR (Fig. 7F). These findings suggested that Y099-Lip-Gel suppresses senescence by inhibiting senescence inducers and the SASP factors.
3.6 Y099-Lip-Gel has a significant influence on phosphoproteomics and inhibits MAPK and NF-κB signaling activations
Phosphoproteomics analysis was performed to reveal the effects of Y099-Lip-Gel on the kinome (Fig. 8A). As shown in Fig. 8B and C, 568 phosphosites of 155 kinases are identified in chondrocytes, among which 66 phosphosites of 44 kinases were significantly regulated by Y099-Lip-Gel. Moreover, according to the significant phosphosite number, the top 5 kinase categories are CAMK (18.2%), STE (18.2%), CMGC (16.7%), and TK (12.1%) (Fig. 8C). Since the kinome tree did not show the tendency of Y099-Lip-Gel among kinase categories (Fig. 8B), GSEA was employed to determine which categories were polarized by Y099-Lip-Gel. As shown in Fig. 8D, the phosphorylation of CAMK, STE, and TK was significantly suppressed by Y099-Lip-Gel. Among the 66 phosphosites, only 9 phosphosites (13.6%) in 6 kinases, including Fyn, Cit, Prpf4b, Bmp2k, Map3k7, and Cdk14, were subjected to enhanced phosphorylation, whereas most of them (86.4%) was suppressed by Y099-Lip-Gel (Fig. 8E). Of note, according to the perturbation amplitudes of phosphorylation, the top 15 suppressed kinases included Ripk2 (TKL), Stk4 (STE), Dclk1 (CAMK), Stk26 (STE), Baz1b (Atypical), Epha2 (TK), Phkg2 (CAMK), Peak1 (Other), Aak1 (Other), Mark1 (CAMK), Gsk3a (CMGC), Cdc42bpb (AGC), Mast4 (AGC), Src (TK), and Csnk1e (CK1) (Fig. 8E). To investigate the function of the significantly regulated kinases, GO analysis was performed, which showed that they are related to stress-activated MAPK cascade, regulation of MAP kinase activity, ERK1 and ERK2 cascade, JNK cascade, activation of MAPK activity, positive regulation of I-kappaB kinase/NF-kappaB signaling, regulation of JNK cascade, and I-kappaB kinase/NF-kappaB signaling (Fig. 9A), suggesting that Y099-Lip-Gel inhibits MAPK and NF-κB signaling activations. Moreover, the pathways associated with aging, senescence, oxidative stress, catabolic process, and IL-1 and IL-6 response were indicated by GO analysis (Fig. 9A). Of note, Ripk2 and Ripk1 showed a high-degree connection with the enriched pathways (Fig. 9A). Western blot further validated that Y099-Lip-Gel suppressed the phosphorylation of ERK1/2, JNK, P65, and IKKα/β induced by IL-1β (Fig. 9B).
3.7 Y099-Lip-Gel exhibits a therapeutic effect on human OA cartilage by promoting aggrecan and suppressing MMP-13 and senescence makers
To explore whether Y099-Lip-Gel has therapeutic effects on human OA cartilage, human OA cartilage explants were harvested from the medial femoral condyle of TKA patients and subjected to Y099-Lip-Gel treatment (Fig. 10A). The cartilage explants from the same patients were divided into two, which were maintained in the IL-1β-contained culture medium to preserve the gene expression of OA phenotypes and treated with or without Y099-Lip-Gel for 48 h, respectively (Fig. 10A). As shown in Fig. 10B, the cartilage explants are around 5 × 5 × 5 mm3 with a complete cartilage-subchondral bone structure (~ 2 mm cartilage and ~ 3 mm subchondral bone in thickness). Safranin O-fast green staining showed OA-related histological characteristics, such as the loss of the cartilage content and chondrocytes and the wear of the cartilage surface (Fig. 10C). To check the effects of Y099-Lip-Gel on anabolism, catabolism, and senescence, the IHC analyses of aggrecan, MMP-13, and P21Cip1 were performed, which showed that the Y099-Lip-Gel was efficient to increase the abundance of aggrecan and suppress the expression of MMP-13 and P21Cip1 in the human OA cartilage after 48-h treatment (Fig. 10D and E). These findings supported that Y099-Lip-Gel had a therapeutic effect on human OA cartilage by promoting aggrecan and suppressing MMP-13 and senescence-related gene expression.
4 Discussion
In the present study, the nanoliposome-based thermosensitive hydrogel system succeeded in reducing kinase inhibition-induced cytotoxicity, enhancing cellular tolerance to kinome perturbation, and improving the performance of Y099 in promoting anabolism of cartilage. The findings of this study demonstrated that nanoliposomal Y099 has a pronounced effect on promoting anabolism via notably increasing Sox9 expression and on suppressing catabolism and inflammation, without causing the inhibition of chondrocyte viability. Moreover, this study suggested that nanoliposomal Y099 can attenuate OA cartilage lesions and preserve subchondral bone by rescuing the OA-related transcriptomic perturbation, regulating kimone modifications, and inhibiting cellular senescence and the SASP productions via inhibiting the MAPK and NF-κB signaling pathways. This study demonstrates the potential of Y099 in OA therapy and proposes a promising and novel strategy of senescence elimination via toxicity-exempted kinome perturbations achieved by advanced nanotechnology for OA.
Targeting senescence by nanoscale platforms has been suggested as an effective strategy for OA. Ren et al. reported that ceria nanoparticles could eliminate the senescent synoviocytes in the rat OA model [53]. The thermosensitive hydrogel loaded with hydroxytyrosol-encapsulated chitosan nanoparticles succeeded in suppressing oxidative stress and inflammation and reducing the senescent cells induced by hydrogen peroxide [54]. However, the exact mechanisms by which these nanoparticles eliminate senescence are largely unknown. RNA interference combined with nanoscale delivery platforms has also been shown to reduce chondrocyte senescence and slow the progression of OA. Zhu et al. proposed a novel injectable self-assembling peptide nanofiber hydrogel to deliver aging-related mir-29b-5p, which exhibited the capabilities of senescence elimination, anabolism promotion, catabolism inhibition, and cartilage repair [55]. Moreover, a direct strategy targeting senescence facilitated by p16INK4a siRNA-loaded PLGA nanoparticles was proven to suppress p16INK4a in fibroblast-like synoviocytes [56]. Although the senescence elimination effects of RNA-based strategies have been demonstrated, single miRNA or siRNA targeting might fail since the intracellular RNA regulation network is complicated and dynamic. Compared with the existing studies, the present study is the first to target senescence by a kinome perturbation strategy facilitated by the nanoliposome-loaded hydrogel. Many kinases and related signaling pathways have also been implied in cellular senescence and the SASP productions in OA. Kinome perturbation is a comprehensive strategy modifying a batch of senescence-related kinases, thus widely inhibiting the expression of the downstream senescence-related genes.
Current protein kinase inhibitors, which have been developed since 2001 when the first tyrosine kinase inhibitor imatinib was approved for chronic myeloid leukemia, are most for cancer therapy [57]. Very few of them, such as tofacitinib and upadacitinib, are approved for skeleton diseases [58, 59]. Although the functions of various protein kinases, such as the MAPK family, have been well-characterized in OA mechanisms [18, 60], no protein kinase inhibitors have been approved for OA therapy. The insufficient selectivity and off-target toxicity of kinase inhibitors, which are caused by the sequence and structural similarities shared by protein kinase families [61], hinder the development of protein kinase inhibitors. The challenges also include the toxicity facilitated by elevated lipophilicity which causes the binding to adventitious targets [62]. Rationally designed nanoplatforms have strength in sustained and controlled release of the drug, thus enhancing the bioavailability and reducing the dose-related toxicity [28, 63]. Nanoliposomes are biocompatible, biodegradable, low toxic, and site-specific for both hydrophilic and hydrophobic drugs [64]. Lecithin is a type of natural phospholipid wildly used for nanoparticle synthesis and drug delivery [65]. The present study utilized lecithin nanoliposomes, which are simple to prepare and effective at reducing drug toxicity while enhancing the beneficial effects of the drug.
The existing treatments used in clinical practices have significant drawbacks, such as gastrointestinal issues caused by systemic administration of nonsteroidal anti-inflammatory drugs and the lack of clarity regarding the effectiveness of intra-articular corticosteroids or hyaluronic acid. Moreover, the low accumulation and retention of drugs in joints resulting from conventional systemic or intra-articular administrations lead to decreased drug efficacy and dose-limiting toxicities. Hydrogels, like the PLGA-PEG-PLGA thermosensitive hydrogels, are beneficial due to their biocompatibility, lack of toxicity, biodegradability, and excellent absorption ability, which make them an ideal choice for intra-articular drug delivery [64, 66]. The thermosensitive hydrogel in the present study prolonged the retention and release of nanoliposomal Y099, as well as promoted the stability of nanoliposomes. Thus, Y099-Lip-Gel has the potential to be utilized as a novel therapy for the treatment of OA.
Several limitations need to be considered in this study. First, although the injections could retain and work locally in the joint cavity, the delivery system in the present study lacks the targeting effects of cartilage. A composite and pleiotropic drug delivery system with high delivery efficiency and specific targeting ability is expected to further improve Y099-Lip-Gel. Secondly, the mechanical properties of Y099-Lip-Gel were not assessed in this study. More efforts are needed to develop a physical-activity-adapted and mechanic-resistant hydrogel to improve its therapeutic effects. Moreover, since the effects of Y099-Lip-Gel on the other joint elements were not assessed, whether Y099-Lip-Gel affected them remained unclear. Finally, although histological assessments of key organs were performed for the evaluation of systemic toxicity, the complete blood count and biochemical indicators of peripheral blood were absent.
5 Conclusions
Nanoliposomal Y099-loaded thermosensitive hydrogel rescues the OA-related transcriptome and regulates kinome modifications to suppress catabolism, promote anabolism, and eliminate cellular senescence. Nanoliposomal Y099-loaded thermosensitive hydrogel is simple to prepare, effective at reducing drug toxicity, prolonging retention and release, promoting stability, and enhancing the beneficial effects of the drug; thus, it has the potential to be a novel therapeutic agent for OA. Nanoliposome-based hydrogel system has strength in reducing kinase inhibition-induced cytotoxicity, enhancing cellular tolerance to kinome perturbation, and improving the performance of protein kinase inhibitors. Senescence elimination via toxicity-exempted kinome perturbations achieved by advanced nanotechnology is a promising strategy for OA.
Data availability
The data are available from the corresponding author upon reasonable request.
References
Hunter DJ, Bierma-Zeinstra S (2019) Osteoarthritis. Lancet 393(10182):1745–1759
Zhou J, He Z, Cui J, Liao X, Cao H, Shibata Y, Miyazaki T, Zhang J (2022) Identification of mechanics-responsive osteocyte signature in osteoarthritis subchondral bone. Bone Joint Res 11(6):362–370
Hernandez-Segura A, Nehme J, Demaria M (2018) Hallmarks of cellular senescence. Trends Cell Biol 28(6):436–453
Coryell PR, Diekman BO, Loeser RF (2021) Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol 17(1):47–57
Cui J, Shibata Y, Zhu T, Zhou J, Zhang J (2022) Osteocytes in bone aging: advances, challenges, and future perspectives. Ageing Res Rev 77
Huang W, Hickson LJ, Eirin A, Kirkland JL, Lerman LO (2022) Cellular senescence: the good, the bad and the unknown. Nat Rev Nephrol 18(10):611–627
Zhang H, Cao X, Tang M, Zhong G, Si Y, Li H, Zhu F, Liao Q, Li L, Zhao J et al (2021)A subcellular map of the human kinome. Elife 10
Zarrin AA, Bao K, Lupardus P, Vucic D (2021) Kinase inhibition in autoimmunity and inflammation. Nat Rev Drug Discov 20(1):39–63
Amirthalingam M, Palanisamy S, Tawata S (2021) p21-Activated kinase 1 (PAK1) in aging and longevity: An overview. Ageing Res Rev 71
Ayala-Aguilera CC, Valero T, Lorente-Macias A, Baillache DJ, Croke S, Unciti-Broceta A (2022) Small molecule kinase inhibitor drugs (1995–2021): medical indication, pharmacology, and synthesis. J Med Chem 65(2):1047–1131
Guo Q, Chen X, Chen J, Zheng G, **e C, Wu H, Miao Z, Lin Y, Wang X, Gao W et al (2021) STING promotes senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the NF-kappaB signaling pathway. Cell Death Dis 12(1):13
Weng PW, Pikatan NW, Setiawan SA, Yadav VK, Fong IH, Hsu CH, Yeh CT, Lee WH (2022)Role of GDF15/MAPK14 axis in chondrocyte senescence as a novel senomorphic agent in osteoarthritis. Int J Mol Sci 23(13)
Novikov FN, Panova MV, Titov IY, Stroylov VS, Stroganov OV, Chilov GG (2021) Inhibition of SYK and cSrc kinases can protect bone and cartilage in preclinical models of osteoarthritis and rheumatoid arthritis. Sci Rep 11(1):23120
Wei Y, Luo L, Gui T, Yu F, Yan L, Yao L, Zhong L, Yu W, Han B, Patel JM et al (2021)Targeting cartilage EGFR pathway for osteoarthritis treatment. Sci Transl Med 13(576)
Wein MN, Liang Y, Goransson O, Sundberg TB, Wang J, Williams EA, O’Meara MJ, Govea N, Beqo B, Nishimori S et al (2016) SIKs control osteocyte responses to parathyroid hormone. Nat Commun 7:13176
Tang CC, Castro Andrade CD, O'Meara MJ, Yoon SH, Sato T, Brooks DJ, Bouxsein ML, Martins JDS, Wang J, Gray NS et al (2021)Dual targeting of salt inducible kinases and CSF1R uncouples bone formation and bone resorption. Elife 10
Hu W, Chen Y, Dou C, Dong S (2021) Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis. Ann Rheum Dis 80(4):413–422
Ferrao Blanco MN, Domenech Garcia H, Legeai-Mallet L, van Osch G (2021) Tyrosine kinases regulate chondrocyte hypertrophy: promising drug targets for Osteoarthritis. Osteoarthritis Cartilage 29(10):1389–1398
Tarumoto Y, Lin S, Wang J, Milazzo JP, Xu Y, Lu B, Yang Z, Wei Y, Polyanskaya S, Wunderlich M et al (2020) Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo. Blood 135(1):56–70
Li F, Li Q, Kimura H, **e X, Zhang X, Wu N, Sun X, Xu BB, Algadi H, Pashameah RA et al (2023) Morphology controllable urchin-shaped bimetallic nickel-cobalt oxide/carbon composites with enhanced electromagnetic wave absorption performance. J Mater Sci Technol 148:250–259
Hou C, Yang W, Kimura H, **e X, Zhang X, Sun X, Yu Z, Yang X, Zhang Y, Wang B et al (2023) Boosted lithium storage performance by local build-in electric field derived by oxygen vacancies in 3D holey N-doped carbon structure decorated with molybdenum dioxide. J Mater Sci Technol 142:185–195
Mu Q, Liu R, Kimura H, Li J, Jiang H, Zhang X, Yu Z, Sun X, Algadi H, Guo Z et al (2022) Supramolecular self-assembly synthesis of hemoglobin-like amorphous CoP@N, P-doped carbon composites enable ultralong stable cycling under high-current density for lithium-ion battery anodes. Adv Compos Hybrid Mater 6(1):23
Hou C, Wang B, Murugadoss V, Vupputuri S, Chao Y, Guo Z, Wang C, Du W (2020) Recent advances in Co3O4 as anode materials for high-performance lithium-ion batteries. Eng Sci 11:19–30
Yang W, Peng D, Kimura H, Zhang X, Sun X, Pashameah RA, Alzahrani E, Wang B, Guo Z, Du W et al (2022) Honeycomb-like nitrogen-doped porous carbon decorated with Co3O4 nanoparticles for superior electrochemical performance pseudo-capacitive lithium storage and supercapacitors. Adv Compos Hybrid Mater 5(4):3146–3157
Dang C, Mu Q, **e X, Sun X, Yang X, Zhang Y, Maganti S, Huang M, Jiang Q, Seok I et al (2022) Recent progress in cathode catalyst for nonaqueous lithium oxygen batteries: a review. Adv Compos Hybrid Mater 5(2):606–626
Ma Y, **e X, Yang W, Yu Z, Sun X, Zhang Y, Yang X, Kimura H, Hou C, Guo Z et al (2021) Recent advances in transition metal oxides with different dimensions as electrodes for high-performance supercapacitors. Adv Compos Hybrid Mater 4(4):906–924
Kim BY, Rutka JT, Chan WC (2010) Nanomedicine. N Engl J Med 363(25):2434–2443
Al-Lawati H, Binkhathlan Z, Lavasanifar A (2019) Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: a review of preclinical research. Eur J Pharm Biopharm 142:179–194
Lu W, Yao J, Zhu X, Qi Y (2021) Nanomedicines: redefining traditional medicine. Biomed Pharmacother 134
** GZ (2020)Current nanoparticle-based technologies for osteoarthritis therapy. Nanomaterials (Basel) 10(12)
Seo BB, Kwon Y, Kim J, Hong KH, Kim SE, Song HR, Kim YM, Song SC (2022) Injectable polymeric nanoparticle hydrogel system for long-term anti-inflammatory effect to treat osteoarthritis. Bioact Mater 7:14–25
Yin M, Zhang J, Zeng X, Zhang H, Gao Y (2021) Target identification and drug discovery by data-driven hypothesis and experimental validation in ovarian endometriosis. Fertil Steril 116(2):478–492
Liang S, Lv ZT, Zhang JM, Wang YT, Dong YH, Wang ZG, Chen K, Cheng P, Yang Q, Guo FJ et al (2018) Necrostatin-1 attenuates trauma-induced mouse osteoarthritis and IL-1beta induced apoptosis via HMGB1/TLR4/SDF-1 in primary mouse chondrocytes. Front Pharmacol 9:1378
Kim GW, Han MS, Park HR, Lee EJ, Jung YK, Usmani SE, Ulici V, Han SW, Beier F (2015) CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation. Osteoarthritis Cartilage 23(6):966–974
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4):402–408
Zhang J, Hao X, Chi R, Qi J, Xu T (2021) Moderate mechanical stress suppresses the IL-1beta-induced chondrocyte apoptosis by regulating mitochondrial dynamics. J Cell Physiol 236(11):7504–7515
Ao Y, Wu Z, Liao Z, Lan J, Zhang J, Sun P, Liu B, Wang Z (2023)Role of C-terminal phosphorylation of lamin A in DNA damage and cellular senescence. Cells 12(4)
Zhang J, Hao X, Chi R, Liu J, Shang X, Deng X, Qi J, Xu T (2022) Whole transcriptome map** identifies an Immune- and metabolism-related non-coding RNA Landscape remodeled by mechanical stress in IL-1beta-induced rat OA-like chondrocytes. Front Genet 13
Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550
Kolde R, Laur S, Adler P, Vilo J (2012) Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics 28(4):573–580
Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284–287
Avelar RA, Ortega JG, Tacutu R, Tyler EJ, Bennett D, Binetti P, Budovsky A, Chatsirisupachai K, Johnson E, Murray A et al (2020) A multidimensional systems biology analysis of cellular senescence in aging and disease. Genome Biol 21(1):91
Liu F, Gai X, Wu Y, Zhang B, Wu X, Cheng R, Tang B, Shang K, Zhao N, Deng W et al (2022) Oncogenic beta-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer. Proc Natl Acad Sci U S A 119(39)
**ao J, Zhang L, Yi H, Zou L, Mo J, Xue F, Zheng J, Huang Y, Lu H, Wu H et al (2022) Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC. Cell Death Dis 13(9):828
Manteca A, Sanchez J, Jung HR, Schwammle V, Jensen ON (2010) Quantitative proteomics analysis of Streptomyces coelicolor development demonstrates that onset of secondary metabolism coincides with hypha differentiation. Mol Cell Proteomics 9(7):1423–1436
Metz KS, Deoudes EM, Berginski ME, Jimenez-Ruiz I, Aksoy BA, Hammerbacher J, Gomez SM, Phanstiel DH (2018)Coral: clear and customizable visualization of human kinome data. Cell Syst 7(3):347–350 e341
Hao X, Zhang J, Shang X, Sun K, Zhou J, Liu J, Chi R, Xu T (2022) Exercise modifies the disease-relevant gut microbial shifts in post-traumatic osteoarthritis rats. Bone Joint Res 11(4):214–225
Glasson SS, Chambers MG, Van Den Berg WB, Little CB (2010) The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage 18(Suppl 3):S17-23
Mankin HJ, Johnson ME, Lippiello L (1981)Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. III. Distribution and metabolism of amino sugar-containing macromolecules. J Bone Joint Surg Am 63(1):131–139
McNulty MA, Loeser RF, Davey C, Callahan MF, Ferguson CM, Carlson CS (2011) A comprehensive histological assessment of osteoarthritis lesions in mice. Cartilage 2(4):354–363
Lotinun S, Ishihara Y, Nagano K, Kiviranta R, Carpentier VT, Neff L, Parkman V, Ide N, Hu D, Dann P et al (2019) Cathepsin K-deficient osteocytes prevent lactation-induced bone loss and parathyroid hormone suppression. J Clin Invest 129(8):3058–3071
Cui J, Shibata Y, Itaka K, Zhou J, Zhang J (2022) Unbiased comparison and modularization identify time-related transcriptomic reprogramming in exercised rat cartilage: integrated data mining and experimental validation. Front Physiol 13
Ren X, Zhuang H, Jiang F, Zhang Y, Zhou P (2023)Ceria Nanoparticles alleviated osteoarthritis through attenuating senescence and senescence-associated secretory phenotype in synoviocytes. Int J Mol Sci 24(5)
Valentino A, Conte R, De Luca I, Di Cristo F, Peluso G, Bosetti M, Calarco A (2022)Thermo-responsive gel containing hydroxytyrosol-chitosan nanoparticles (Hyt@tgel) counteracts the increase of osteoarthritis biomarkers in human chondrocytes. Antioxidants (Basel) 11(6)
Zhu J, Yang S, Qi Y, Gong Z, Zhang H, Liang K, Shen P, Huang YY, Zhang Z, Ye W et al (2022)Stem cell-homing hydrogel-based miR-29b-5p delivery promotes cartilage regeneration by suppressing senescence in an osteoarthritis rat model. Sci Adv8(13):eabk0011
Park H, Lee HR, Shin HJ, Park JA, Joo Y, Kim SM, Beom J, Kang SW, Kim DW, Kim J (2022) p16INK4a-siRNA nanoparticles attenuate cartilage degeneration in osteoarthritis by inhibiting inflammation in fibroblast-like synoviocytes. Biomater Sci 10(12):3223–3235
Cohen P, Cross D, Janne PA (2021) Kinase drug discovery 20 years after imatinib: progress and future directions. Nat Rev Drug Discov 20(7):551–569
Dhillon S (2017) Tofacitinib: a review in rheumatoid arthritis. Drugs 77(18):1987–2001
Rubbert-Roth A, Enejosa J, Pangan AL, Haraoui B, Rischmueller M, Khan N, Zhang Y, Martin N, Xavier RM (2020) Trial of upadacitinib or abatacept in rheumatoid arthritis. N Engl J Med 383(16):1511–1521
Fukui T, Yik JHN, Doyran B, Davis J, Haudenschild AK, Adamopoulos IE, Han L, Haudenschild DR (2021) Bromodomain-containing-protein-4 and cyclin-dependent-kinase-9 inhibitors interact synergistically in vitro and combined treatment reduces post-traumatic osteoarthritis severity in mice. Osteoarthritis Cartilage 29(1):68–77
Moran G, Elaine A (2021)Protein kinase inhibitors - selectivity or toxicity? In: Protein Kinases. edn. Edited by Rajesh Kumar S. Rijeka: IntechOpen Ch. 2
Roskoski R Jr (2023) Properties of FDA-approved small molecule protein kinase inhibitors: a 2023 update. Pharmacol Res 187
Velpurisiva P, Piel BP, Lepine J, Rai P (2018) GSK461364A, a polo-like kinase-1 inhibitor encapsulated in polymeric nanoparticles for the treatment of glioblastoma multiforme (GBM). Bioengineering (Basel)5(4)
Singh AP, Biswas A, Shukla A, Maiti P (2019) Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal Transduct Target Ther 4:33
Li J, Wang X, Zhang T, Wang C, Huang Z, Luo X, Deng Y (2015) A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci 10(2):81–98
Cao H, Duan L, Zhang Y, Cao J, Zhang K (2021) Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity. Signal Transduct Target Ther 6(1):426
Funding
This study was supported by Grants-in-Aid for Research Activity Start-up (Grant No. 19K24154) from Japan Society for the Promotion of Science (Jun Zhou) and the National Natural Science Foundation of China (Grant No. 81902262) (Anmin Chen).
Author information
Authors and Affiliations
Contributions
Junlai Wan: investigation (cell experiments and human explant study), methodology, data curation, writing – review & editing; Zhiyi He: investigation (cell experiments and animal study), data curation, writing – review & editing; Yingchao Zhao: conceptualization, methodology, writing – original draft (supplementary); **aoxia Hao: data curation; Jiarui Cui: visualization (graphical illustrations); Anmin Chen: supervision, funding acquisition; Jun Zhou: conceptualization, project administration, investigation (preparation, synthesis, analyses of nanoscale drug), supervision, resources, funding acquisition, data curation, writing – original draft (supplementary); J. Zhang: conceptualization, project administration, methodology, investigation (histomorphometric analyses, transcriptomic and phosphoproteomic analyses, bioinformatic analyses, statistics), data curation, visualization (all the figures), writing – original draft (main). All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wan, J., He, Z., Zhao, Y. et al. Novel strategy of senescence elimination via toxicity-exempted kinome perturbations by nanoliposome-based thermosensitive hydrogel for osteoarthritis therapy. Adv Compos Hybrid Mater 6, 104 (2023). https://doi.org/10.1007/s42114-023-00673-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s42114-023-00673-w